Do pathogens always evolve to be less virulent? The virulence-transmission trade-off in light of the COVID-19 pandemic

被引:8
|
作者
Kun, Adam [1 ,2 ,3 ,7 ]
Hubai, Andras G. [1 ,4 ,5 ]
Kral, Adrienn [1 ,2 ]
Mokos, Judit [1 ,2 ,4 ,7 ]
Mikulecz, Benjamin Aron [1 ]
Radvanyi, Adam [1 ,6 ]
机构
[1] Eotvos Lorand Univ, Inst Biol, Dept Plant Systemat Ecol & Theoret Biol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary
[2] Ctr Ecol Res, Inst Evolut, Konkoly Thege M Ut 29-33, H-1121 Budapest, Hungary
[3] Parmenides Fdn, Parmenides Ctr Conceptual Fdn Sci, Hindenburgstr 15, D-82343 Pocking, Germany
[4] MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary
[5] Alfred Reny Inst Math, Realtanoda St 13-15, H-1053 Budapest, Hungary
[6] Moholy Nagy Univ Art & Design, Ctr Data Sci & Digital Dev, Zugliget Ut 9-25, H-1121 Budapest, Hungary
[7] Eotvos Lorand Univ, Natl Lab Hlth Secur, Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
COVID-19; SARS-CoV2; Epidemiology; Evolution of virulence; Virulence-transmission trade-off; Law of declining virulence; Avirulence hypothesis; INCUBATION PERIOD; HIV EPIDEMIC; MYXOMA VIRUS; EVOLUTION; SARS-COV-2; HOST; EMERGENCE; COINFECTION; INFECTIONS; VARIANT;
D O I
10.1007/s42977-023-00159-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The direction the evolution of virulence takes in connection with any pathogen is a long-standing question. Formerly, it was theorized that pathogens should always evolve to be less virulent. As observations were not in line with this theoretical outcome, new theories emerged, chief among them the transmission-virulence trade-off hypotheses, which predicts an intermediate level of virulence as the endpoint of evolution. At the moment, we are very much interested in the future evolution of COVID-19's virulence. Here, we show that the disease does not fulfill all the assumptions of the hypothesis. In the case of COVID-19, a higher viral load does not mean a higher risk of death; immunity is not long-lasting; other hosts can act as reservoirs for the virus; and death as a consequence of viral infection does not shorten the infectious period. Consequently, we cannot predict the short- or long-term evolution of the virulence of COVID-19.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
  • [21] From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
    Antoine AbdelMassih
    Abrar Sedky
    Ahmed Shalaby
    AlAmira-Fawzia Shalaby
    Alia Yasser
    Aya Mohyeldin
    Basma Amin
    Basma Saleheen
    Dina Osman
    Elaria Samuel
    Emmy Abdelfatah
    Eveen Albustami
    Farida ElGhamry
    Habiba Khaled
    Hana Amr
    Hanya Gaber
    Ismail Makhlouf
    Janna Abdeldayem
    Jana Waleed El-Beialy
    Karim Milad
    Laila El Sharkawi
    Lina Abosenna
    Madonna G. Safi
    Mariam AbdelKareem
    Marwa Gaber
    Mirna Elkady
    Mohamed Ihab
    Nora AbdelRaouf
    Rawan Khaled
    Reem Shalata
    Rudayna Mahgoub
    Sarah Jamal
    Seif El-Din El Hawary
    Shady ElRashidy
    Sherouk El Shorbagy
    Tony Gerges
    Yara Kassem
    Yasmeen Magdy
    Yasmin Omar
    Yasmine Shokry
    Aya Kamel
    Rafeef Hozaien
    Nadine El-Husseiny
    Meryam El Shershaby
    Bulletin of the National Research Centre, 46 (1)
  • [22] The equity-efficiency trade-off and the intensity of COVID-19 pandemic government responses: evidence from US states
    Christopoulos, Konstantinos
    Eleftheriou, Konstantinos
    Nijkamp, Peter
    REGIONAL STUDIES, 2024, 58 (02) : 350 - 364
  • [23] COVID-19 and a trade-off between health and economics: an extended inoperability model for Italy
    Socci, Claudio
    Ahmed, Irfan
    Alfify, Mohammed Hussein
    Deriu, Stefano
    Ciaschini, Clio
    Sheikh, Riyaz Abdullah
    KYBERNETES, 2023, 52 (01) : 121 - 137
  • [24] Effectiveness of feedback control and the trade-off between death by COVID-19 and costs of countermeasures
    Akira Watanabe
    Hiroyuki Matsuda
    Health Care Management Science, 2023, 26 : 46 - 61
  • [25] Effectiveness of feedback control and the trade-off between death by COVID-19 and costs of countermeasures
    Watanabe, Akira
    Matsuda, Hiroyuki
    HEALTH CARE MANAGEMENT SCIENCE, 2023, 26 (01) : 46 - 61
  • [26] The trade-off between mobility and vaccination for COVID-19 control: a metapopulation modelling approach
    Saldana, Fernando
    Velasco-Hernandez, Jorge X.
    ROYAL SOCIETY OPEN SCIENCE, 2021, 8 (06):
  • [27] Economy versus epidemiology: an analysis of trade-off between markets and lives in COVID-19 times
    Sameer El Khatib, Ahmed
    CONTABILIDAD Y NEGOCIOS, 2020, 15 (30) : 62 - 80
  • [28] Ethics Trade-Off Between Hazards Prevention and the Safeguard of Death Dignity During COVID-19
    Logar, Silvia
    Leese, Maggie
    OMEGA-JOURNAL OF DEATH AND DYING, 2022, 86 (01) : 21 - 24
  • [29] The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications
    Khan, Sohil
    Gionfriddo, Michael R.
    Cortes-Penfield, Nicolas
    Thunga, Girish
    Rashid, Muhammad
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (15) : 1821 - 1850
  • [30] The Volatility and Risk-Return Trade-Off of Malaysian Islamic and Conventional Indexes During the Global Financial Crisis and COVID-19 Pandemic
    Min, Foo Siong
    Ab Razak, Nazrul Hisyam
    Kamarudin, Fakarudin
    Zakaria, Nadisah
    ASIAN JOURNAL OF BUSINESS AND ACCOUNTING, 2023, 16 (02): : 1 - 43